Iambic Therapeutics Stock
HealthTechLooking to sell Iambic Therapeutics stock or options?
Iambic Therapeutics has developed a cutting-edge quantum molecular simulation engine focused on expediting the discovery of new therapeutics. This innovative engine integrates AI-driven technology with automated synthesis processes to swiftly design small-molecule drugs. This enables healthcare professionals to achieve molecular predictions with significantly enhanced accuracy, transforming the landscape of drug discovery.
Alumni Ventures, University of Bristol, Tao Capital, OrbiMed, Nexus Venture Partners, Chestnut Street Ventures, Exor, Catalio Capital Management, Freeflow Ventures, Gradiant, Schmidt Futures, Abingworth, Illumina Ventures, Bill Rastetter, Techstars, Ascenta Capital, Tao Capital Partners, Nvidia, Mubadala Capital, Shanda Group, Sequoia Capital, Qatar Investment Authority, Coatue Management.